Dividend Information about Crescent Capital: Everything You Need to Know Before the Ex-Dividend Date on Aug 29, 2025

Generado por agente de IAAinvest Dividend Digest
lunes, 25 de agosto de 2025, 8:56 pm ET1 min de lectura
CCAP--
Crescent Capital (CCAP) has announced its upcoming cash dividend, offering $0.05000000 per share, with an ex-dividend date of Aug 29, 2025. The dividend will be paid on Sep 15, 2025, and the announcement was made on Feb 19, 2025. This upcoming payout represents a significant drop compared to the 10-year average dividend per share of $0.291470588, which underscores a shift in the company's dividend policy or financial strategy. The last dividend was paid on Jul 15, 2025, at $0.42000000 per share, also a cash dividend. Investors should note the upcoming ex-dividend date as the last day to purchase the stock and still be eligible for the dividend—any purchases made after this date will not qualify for the payout.

Over the past week, Crescent CapitalCCAP-- has seen several significant developments that may influence its market performance and investor sentiment. BI Asset Management Fondsmaeglerselskab A S recently acquired 18,078 shares of CCAPCCAP--, signaling growing institutional interest in the stock. Additionally, CrescentCBIO-- Capital reported Q2 earnings of $0.46 per share, aligning with analyst estimates and reflecting stable financial performance. More recently, the company is set to merge with another entity, with Crescent shareholders expected to own approximately 77% of the combined company by year-end 2025. This strategic move could reshape the company’s structure and market position, offering long-term value to existing investors.

Analysts have also highlighted Crescent Capital’s attractive 11% dividend yield, coupled with a 22% discount to its net asset value, which provides a strong margin of safety for potential investors. Meanwhile, the options market has shown heightened activity, with traders anticipating potential volatility around key dates, including the ex-dividend date. As of late, the stock has received a positive outlook from analysts, with five Buy ratings and an average price target of $16.38 in the past three months. These factors combined suggest a compelling opportunity for investors seeking income and capital appreciation from a well-positioned business development company.

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios